Академический Документы
Профессиональный Документы
Культура Документы
MANAGEMENT of
GERD
Wizhar Syamsuri
Physiologic vs Pathologic
Physiologic GERD
Postprandial
Short lived
Asymptomatic
No nocturnal sx
Pathologic GERD
Symptoms
Mucosal injury
Nocturnal sx
Incidence
It is one of the most common conditions
affecting the gastrointestinal system.
Anywhere from 36-77% of people have symptoms of
GERD (heartburn, regurgitation of acid etc.) spread
equally between men and women.
Epidemiology GERD
J Dent, H B El-Serag, M-A Wallander and S Johansson 2005;54;710-717 Gut ; a systematic review Epidemiology of gastro-oesophageal reflux disease
Regurgitation
Effortless return of food or gastric contents
from stomach into esophagus or mouth
Described as hot, bitter, or sour liquid coming
into the mouth or throat
Epigastric pain
Regurgitation
Nausea
Belching
Bloating
without
esophagitis
with esophagitis
Abdominal pain
Carlsson et al 1998b
Complications of GERD
Erosive/ulcerative esophagitis
Esophageal (peptic) stricture
Barretts esophagus
Adenocarcinoma
Normal
40-50%
Esophagitis
30-50%
Stricture
10 - 20%
Barretts Esophagus
10 - 20%
Peptic Stricture
Barium Swallow
Endoscopy
Diagnostic Studies
History and PE
Barium swallow
Upper GI endoscopy
Monitoring pH
Endoscopy
Indications for endoscopy
Alarm symptoms
Dysphagia
Early satiety
GI bleeding
Odynophagia
Vomiting
Weight loss
Iron deficiency anemia
Upper endoscopy
Most commonly used
test to evaluate the
esophagus and
stomach.
Requires mild sedation
Requires technical skill
and experience
Most accurate way to
evaluate damage to or
inflammation of the
upper gastrointestinal
tract.
Tipe GERD
Patients with GERD
100%
Patients with NERD
60%
Patients without
complications
35%
Patients with
complications
5%
Adapted from Quigley 2001
NERD
Didefinisikan dengan adanya gejalagejala umum, termasuk didalamnya
heartburn ,regurgitasi , nyeri dada dan
gejala extra-esophageal seperti ;
batuk,serak,asthma,yang disebabkan
reflux dari lambung/usus dan tidak ada
kerusakan jaringan pada pemeriksaan
upper endoscopy.
Derajat
kerusakan
Gambaran Endoskopi
Grade B
One (or more)
mucosal break, no
longer than 5 mm,
that does not extend
between the tops of
two mucosal folds
Grade C
Grade D
One (or more)
mucosal break
that is continuous
between the tops
of two or more
mucosal folds,
but which involves
less than 75% of
the circumference
Lundell et al 1999
A.
B.
C.
D.
E.
Esofagus normal
Esofagitis ringan
Esofagitis sedang
Esofagitis berat
Esofagus Barret
Treatment of GERD
(Collaborate Cares)
Goal of Treatment
Eliminate symptoms
Heal esophagitis
Manage or prevent complications
Maintain remission
Stop smoking
Avoid alcohol and caffeine
Avoid acidic foods
Modify diet
Step up
2.
Step down
Step-up
Approaches
Step-down
Approaches
Treatment
H2RAs vs PPIs
12 week freedom from symptoms
48% vs 77%
Speed of healing
6%/wk vs 12%/wk
Healing 80-90%
Maintenance of remission 70-95%
Effectiveness of Medical
Therapies for GERD
Treatment
Response
Lifestyle modifications/antacids
20 %
H2-receptor antagonists
50 %
Single-dose PPI
80 %
Increased-dose PPI
up to 100 %
H2RAs
40
Placebo
20
0
4
6
8
Weeks of treatment
10
12
p < 0.0005
Surgical Therapy
Surgical therapy
Surgical therapy
Necessary if
Surgical therapy
Mengurangi
Gejala
Penyembuhan
Lesi Esofagitis
Mencegah
Komplikasi
Mencegah
Kekambuhan
Antasid
+1
Prokinetik
+2
+1
+1
Antagonis
reseptor H2
+2
+2
+1
+1
Antagonis
reseptor H2+
prokinetik
+3
+3
+1
+1
Antagonis
reseptor H2
dosis tinggi
+3
+3
+2
+2
Penghambat
pompa proton
+4
+4
+3
+4
Pembedahan
+4
+4
+3
+4
2.
3.
4.
5.
Antisecretory drugs for the treatment of patients with esophageal GERD syndromes
(healing esophagitis, symptomatic relief & maintaining healing of esophagitis). In
these uses, PPIs are more effective than H2RAs, which are more effective than
placebo
Long-term use of PPIs for the treatment of patients with esophagitis once they have
proven clinically effective. Long-term therapy should be titrated down to the lowest
effective dose based on symptom control
When antireflux surgery & PPI therapy are judged to offer similar effectiveness in a
patient with an esophageal GERD syndrome, PPI therapy should be recommended
as initial therapy because of superior safety
When a patient with an esophageal GERD syndrome is responsive to, but
intolerant of, acid suppressive therapy, antireflux surgery should be recommended
as an alternative
Twice-daily PPI therapy as an empirical trial for patients with suspected reflux chest
pain syndrome after a cardiac etiology has been carefully considered
* U.S. Preventive Services Task Force Grades - Grade A recommendations (strongly recommended based on good evidence that it improves
important health outcomes)
AGA American Gastroenterological Association, TR Technical Review, MPS Medical Position Statement, PPIs Proton Pump Inhibitors, H2RAs Histamine Receptor Antagonists
Terapi Empiris
Dinamakan juga PPI test
Dosis ganda PPI
1-2 minggu
Positif; bila keluhan hilang 75%
dalam 1 minggu
(weeks)
On-demand
(days)
S
P. Bytzer* & A. L. Blum , Rationale and proposed algorithms for symptom-based proton pump
inhibitor therapy for gastro-oesophageal reflux disease Alimentary Pharmacology & Therapeutics,
Volume 20 Page 389 - August 2004
S
S : symptom recurrence
An Algorithm Approach
On-Demand strategy not appropriate for all
GERD patients.
Algorithm needed to specify:
* Initial evaluation
* Treatment protocols
* Follow-up protocols
P. Bytzer* & A. L. Blum , Rationale and proposed algorithms for symptom-based proton pump
inhibitor therapy for gastro-oesophageal reflux disease Alimentary Pharmacology & Therapeutics,
Volume 20 Page 389 - August 2004
P. Bytzer* & A. L. Blum , Rationale and proposed algorithms for symptom-based proton pump
inhibitor therapy for gastro-oesophageal reflux disease Alimentary Pharmacology & Therapeutics,
Volume 20 Page 389 - August 2004
Success
PPI on demand
Endoscopy
NERD
Mild erosive
esofagitis
Severe erosive
esofagitis
PPI
4 8 weeks
Success:
Continuous PPI
P. Bytzer* & A. L. Blum , Rationale and proposed algorithms for symptom-based proton pump
inhibitor therapy for gastro-oesophageal reflux disease Alimentary Pharmacology & Therapeutics,
Volume 20 Page 389 - August 2004
Endoscopy
NERD
Mild erosive
esofagitis
PPI
4 8 weeks
Success:
On Demand PPI
P. Bytzer* & A. L. Blum , Rationale and proposed algorithms for symptom-based proton pump
inhibitor therapy for gastro-oesophageal reflux disease Alimentary Pharmacology & Therapeutics,
Volume 20 Page 389 - August 2004
Severe erosive
esofagitis
Endoscopy
NERD
Mild erosive
esofagitis
Severe erosive
esofagitis
PPI
4 8 weeks
Success:
On Demand PPI
P. Bytzer* & A. L. Blum , Rationale and proposed algorithms for symptom-based proton pump
inhibitor therapy for gastro-oesophageal reflux disease Alimentary Pharmacology & Therapeutics,
Volume 20 Page 389 - August 2004
Failure:
Prolonged therapy
3
6
1. Pantoflickova D, et al. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
Aliment Pharmacol Ther 2003; 17: 1507-1514
2.Kromer W et al. Differences in pH-Dependent Activation Rates of Substituted Benzimidazoles and Biological in
vitro Correlates.
Pharmacology 1998; 56: 57-70
Pada
HARI 1
Pantoflickova D, et al. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
Aliment Pharmacol Ther 2003; 17: 1507-1514
Pada
HARI
1
4.7%
4.7%
Holtman G, et al. A randomized, double-blind, comparative study of standard-dose rabeprazole and highdose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002; 16: 479-485
80%
HARI 1
Pada
HARI 1
Catatan:
pH optimal adalah pH ideal yang dibutuhkan untuk pengobatan penyakit akibat asam lambung
Ulkus : pH dipertahankan > 3
GERD : pH dipertahankan > 4
Warrington S, et al. Effects of single doses of rabeprazole 20mg and esomeprazole 40mg on 24-h
intragastric pH in healthy subjects. Eur J Pharmacol 2006; 62: 685-691
CEPAT SEMBUH
84%
Holtman G, et al. A randomized, double-blind, comparative study of standard-dose rabeprazole and highdose omeprazole in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002; 16: 479-485